Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;27(2):117-124.
doi: 10.1007/s10151-022-02724-8. Epub 2022 Nov 9.

Protocol for the ORION trial (RadiO fRequency ablatION for haemorrhoids): a randomised controlled trial

Affiliations

Protocol for the ORION trial (RadiO fRequency ablatION for haemorrhoids): a randomised controlled trial

C Girling et al. Tech Coloproctol. 2023 Feb.

Abstract

Background: Haemorrhoids are common and can significantly impact the personal and working lives of individuals. Those with more severe symptoms and those not responding to conservative management may require surgery. Current surgical techniques are associated with a degree of postoperative discomfort which may delay return to normal activity. Recurrence is lower in more radical procedures but resulting pain is higher. Radiofrequency ablation (RFA) is a new technique that is gaining popularity and has several hypothesised benefits, including reduced pain and recurrence. However, available evidence is limited. A recent overview from the National Institute for Health and Clinical Excellence recommended more research, in the form of randomised controlled trials, be carried out before further investment is made by national health services. Our aim is to assess whether RFA is at least as good in terms of recurrence as existing surgical interventions, but superior in terms of pain, for patients with symptomatic grade II and III haemorrhoids.

Methods: The RadiO fRequency ablatION for haemorrhoids (ORION) trial will be a pragmatic multicentre patient/assessor-blind parallel group-controlled trial with economic evaluation. The target sample size is 376 participants (188 per arm) and is based on two co-primary endpoints: (i) a non-inferiority design for recurrence and (ii) superiority design for pain at seven days. Participants with grade II or III haemorrhoids will be recruited in 16 National Health Service hospitals and randomised (1:1) to either RFA or surgeon's choice of surgery.

Conclusions: Results will inform future practice for the treatment of grade II-III haemorrhoids and provide evidence for national health services on future investments in RFA.

Trial registration: ISRCTN14474552.

Keywords: Haemorrhoids; Radiofrequency ablation; Randomised controlled trial; Surgical procedure.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Participant study flow diagram for visits and data collection. EQ-5D-5L EuroQol 5 Dimension 5 Level

References

    1. Loder PB, Kamm MA, Nicholls RJ, Phillips RKS. Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg. 1994;81:946–954. doi: 10.1002/BJS.1800810707. - DOI - PubMed
    1. Burch J, Epstein D, Baba-Akbari A, et al. Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of haemorrhoids: a systematic review and economic evaluation. Health Technol Assess. 2008 doi: 10.3310/HTA12080. - DOI - PubMed
    1. van Tol RR, Kleijnen J, Watson AJM, et al. European Society of ColoProctology: guideline for haemorrhoidal disease. Color Dis. 2020;22:650–662. doi: 10.1111/CODI.14975. - DOI - PubMed
    1. Venara A, Podevin J, Godeberge P, et al. A comparison of surgical devices for grade II and III hemorrhoidal disease. Results from the LigaLongo Trial comparing transanal Doppler-guided hemorrhoidal artery ligation with mucopexy and circular stapled hemorrhoidopexy. Int J Colorectal Dis. 2018;33:1479–1483. doi: 10.1007/S00384-018-3093-8. - DOI - PubMed
    1. Watson AJM, Hudson J, Wood J, et al. Comparison of stapled haemorrhoidopexy with traditional excisional surgery for haemorrhoidal disease (eTHoS): a pragmatic, multicentre, randomised controlled trial. Lancet. 2016;388:2375–2385. doi: 10.1016/S0140-6736(16)31803-7/ATTACHMENT/82EEAE74-5E13-42C3-8974-70FADFD73DC7/MMC1.PDF. - DOI - PMC - PubMed

Publication types